Wang Mengyi, Zhang Shiwu, Tian Jinwei, Yang Fan, Chen He, Bai Shuzhi, Kang Jiaxin, Pang Kemiao, Huang Jiayi, Dong Mingjie, Dong Shiyun, Tian Zhen, Fang Shaohong, Fan Huitao, Lu Fanghao, Yu Bo, Li Shuijie, Zhang Weihua
Department of Cardiology, Second Affiliated Hospital of Harbin Medical University, No. 246 Xuefu ROAD, Harbin, 150086, China.
Heilongjiang Provincial Key Laboratory of Panvascular Disease, Harbin, 150000, China.
Adv Sci (Weinh). 2025 Jan;12(1):e2406695. doi: 10.1002/advs.202406695. Epub 2024 Nov 4.
Diabetic cardiomyopathy (DCM), a severe complication of diabetes, is characterized by mitochondrial dysfunction, oxidative stress, and DNA damage. Despite its severity, the intrinsic factors governing cardiomyocyte damage in DCM remain unclear. It is hypothesized that impaired iron-sulfur (Fe-S) cluster synthesis plays a crucial role in the pathogenesis of DCM. Reduced S-sulfhydration of cysteine desulfurase (NFS1) is a novel mechanism that contributes to mitochondrial dysfunction and PARthanatos in DCM. Mechanistically, hydrogen sulfide (HS) supplementation restores NFS1 S-sulfhydration at cysteine 383 residue, thereby enhancing Fe-S cluster synthesis, improving mitochondrial function, increasing cardiomyocyte viability, and alleviating cardiac damage. This study provides novel insights into the interplay between Fe-S clusters, mitochondrial dysfunction, and PARthanatos, highlighting a promising therapeutic target for DCM and paving the way for potential clinical interventions to improve patient outcomes.
糖尿病性心肌病(DCM)是糖尿病的一种严重并发症,其特征为线粒体功能障碍、氧化应激和DNA损伤。尽管其严重性,但DCM中心肌细胞损伤的内在因素仍不清楚。据推测,铁硫(Fe-S)簇合成受损在DCM的发病机制中起关键作用。半胱氨酸脱硫酶(NFS1)的S-巯基化减少是一种导致DCM中线粒体功能障碍和程序性坏死的新机制。从机制上讲,补充硫化氢(HS)可恢复半胱氨酸383残基处的NFS1 S-巯基化,从而增强Fe-S簇合成,改善线粒体功能,提高心肌细胞活力,并减轻心脏损伤。本研究为Fe-S簇、线粒体功能障碍和程序性坏死之间的相互作用提供了新的见解,突出了DCM一个有前景的治疗靶点,并为改善患者预后的潜在临床干预铺平了道路。